Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02609984
Title Trial of CMB305 and Atezolizumab in Patients With Sarcoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Immune Design
Indications

myxoid liposarcoma

synovial sarcoma

Therapies

Atezolizumab

G305 + ID-LV305

Age Groups: adult
Covered Countries USA


No variant requirements are available.